J Prev Med Public Health.  2022 Sep;55(5):464-474. 10.3961/jpmph.22.299.

The Korea Cohort Consortium: The Future of Pooling Cohort Studies

Affiliations
  • 1Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea
  • 2Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
  • 3Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea
  • 4Clinical Preventive Medicine Center, Seoul National University Bundang Hospital, Seongnam, Korea
  • 5Department of Food and Nutrition, Seoul National University, Seoul, Korea
  • 6Department of Occupational and Environmental Medicine, Hanyang University College of Medicine, Seoul, Korea
  • 7Department of Epidemiology and Health Promotion, Institute for Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, Korea
  • 8Integrated Major in Innovative Medical Science, Seoul National University College of Medicine, Seoul, Korea
  • 9Department of Preventive Medicine, Chonnam National University Medical School, Hwasun, Korea
  • 10Department of Family Medicine, Seoul National University Hospital, Seoul, Korea
  • 11Department of Occupational and Environmental Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 12Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea
  • 13Graduate School of Science and Policy, National Cancer Center, Korea
  • 14Department of Preventive Medicine and Public Health, Catholic Kwandong University College of Medicine, Gangneung, Korea
  • 15Veterans Health Service Medical Center, Seoul, Korea
  • 16Seoul National University College of Medicine, Seoul, Korea

Abstract


Objectives
We introduced the cohort studies included in the Korean Cohort Consortium (KCC), focusing on large-scale cohort studies established in Korea with a prolonged follow-up period. Moreover, we also provided projections of the follow-up and estimates of the sample size that would be necessary for big-data analyses based on pooling established cohort studies, including population-based genomic studies.
Methods
We mainly focused on the characteristics of individual cohort studies from the KCC. We developed “PROFAN”, a Shiny application for projecting the follow-up period to achieve a certain number of cases when pooling established cohort studies. As examples, we projected the follow-up periods for 5000 cases of gastric cancer, 2500 cases of prostate and breast cancer, and 500 cases of non-Hodgkin lymphoma. The sample sizes for sequencing-based analyses based on a 1:1 case-control study were also calculated.
Results
The KCC consisted of 8 individual cohort studies, of which 3 were community-based and 5 were health screening-based cohorts. The population-based cohort studies were mainly organized by Korean government agencies and research institutes. The projected follow-up period was at least 10 years to achieve 5000 cases based on a cohort of 0.5 million participants. The mean of the minimum to maximum sample sizes for performing sequencing analyses was 5917-72 102.
Conclusions
We propose an approach to establish a large-scale consortium based on the standardization and harmonization of existing cohort studies to obtain adequate statistical power with a sufficient sample size to analyze high-risk groups or rare cancer subtypes.

Keyword

Data pooling; Cohort studies; Follow-up studies
Full Text Links
  • JPMPH
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr